{"entity":{"type":"insider","cik":"0001463414","url":"/insider/0001463414","json_url":"/insider/0001463414.json","name":"Mazur Leonard L","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":9,"n_filings":9,"first":"2016-04-12","last":"2022-01-18","span_basis":"filed_date"},"name_variants":[{"name":"Mazur Leonard L","source":"filing","n_filings":9,"first_seen":"2016-04-12","last_seen":"2022-01-18"}],"transactions":[{"id":6684813,"accession":"0001493152-22-001473","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001493152-22-001473","line_url":"/filing/0001493152-22-001473#line-2","is_derivative":false,"issuer_cik":"0001463414","issuer_name":"Hillstream BioPharma Inc.","issuer_ticker":"HILS","issuer_name_source":null,"issuer_url":"/issuer/0001463414","owner_cik":"0001463414","owner_name":"Mazur Leonard L","owner_display_name":"Mazur Leonard L","owner_url":"/insider/0001463414","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25000.0,"shares_display":"25,000","price_per_share":4.0,"price_display":"4.00","price_state":"stated","total_value":100000.0,"total_display":"100,000.00","total_whole":"100,000","shares_owned_after":123733.0,"shares_owned_after_display":"123,733","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-14","filed_date":"2022-01-18","scope":"insider"},{"id":7880105,"accession":"0001213900-19-019180","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-19-019180","line_url":"/filing/0001213900-19-019180#line-1","is_derivative":false,"issuer_cik":"0001463414","issuer_name":"Citius Pharmaceuticals, Inc.","issuer_ticker":"CTXR","issuer_name_source":null,"issuer_url":"/issuer/0001463414","owner_cik":"0001463414","owner_name":"Mazur Leonard L","owner_display_name":"Mazur Leonard L","owner_url":"/insider/0001463414","role":"Director, Officer (Executive Chairman), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Chairman","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2234700.0,"shares_display":"2,234,700","price_per_share":0.8951,"price_display":"0.90","price_state":"stated","total_value":2000279.97,"total_display":"2,000,279.97","total_whole":"2,000,280","shares_owned_after":10255343.0,"shares_owned_after_display":"10,255,343","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-27","filed_date":"2019-09-27","scope":"insider"},{"id":7952427,"accession":"0001213900-19-005844","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-19-005844","line_url":"/filing/0001213900-19-005844#line-1","is_derivative":false,"issuer_cik":"0001463414","issuer_name":"Citius Pharmaceuticals, Inc.","issuer_ticker":"CTXR","issuer_name_source":null,"issuer_url":"/issuer/0001463414","owner_cik":"0001463414","owner_name":"Mazur Leonard L","owner_display_name":"Mazur Leonard L","owner_url":"/insider/0001463414","role":"Director, Officer (Executive Chairman), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Chairman","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1165048.0,"shares_display":"1,165,048","price_per_share":1.545,"price_display":"1.54","price_state":"stated","total_value":1799999.16,"total_display":"1,799,999.16","total_whole":"1,799,999","shares_owned_after":8020643.0,"shares_owned_after_display":"8,020,643","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-04-03","filed_date":"2019-04-05","scope":"insider"},{"id":6712247,"accession":"0001213900-18-011213","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-18-011213","line_url":"/filing/0001213900-18-011213#line-1","is_derivative":false,"issuer_cik":"0001463414","issuer_name":"Citius Pharmaceuticals, Inc.","issuer_ticker":"CTXR","issuer_name_source":null,"issuer_url":"/issuer/0001463414","owner_cik":"0001463414","owner_name":"Mazur Leonard L","owner_display_name":"Mazur Leonard L","owner_url":"/insider/0001463414","role":"Director, Officer (Executive Chairman), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Chairman","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3137255.0,"shares_display":"3,137,255","price_per_share":1.275,"price_display":"1.28","price_state":"stated","total_value":4000000.125,"total_display":"4,000,000.12","total_whole":"4,000,000","shares_owned_after":6855595.0,"shares_owned_after_display":"6,855,595","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-08-13","filed_date":"2018-08-15","scope":"insider"},{"id":6427591,"accession":"0001213900-18-003856","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-18-003856","line_url":"/filing/0001213900-18-003856#line-1","is_derivative":false,"issuer_cik":"0001463414","issuer_name":"Citius Pharmaceuticals, Inc.","issuer_ticker":"CTXR","issuer_name_source":null,"issuer_url":"/issuer/0001463414","owner_cik":"0001463414","owner_name":"Mazur Leonard L","owner_display_name":"Mazur Leonard L","owner_url":"/insider/0001463414","role":"Director, Officer (Executive Chairman), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Chairman","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":167504.0,"shares_display":"167,504","price_per_share":2.985,"price_display":"2.98","price_state":"stated","total_value":499999.44,"total_display":"499,999.44","total_whole":"499,999","shares_owned_after":3718340.0,"shares_owned_after_display":"3,718,340","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-29","filed_date":"2018-04-02","scope":"insider"},{"id":6427545,"accession":"0001213900-18-000250","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-18-000250","line_url":"/filing/0001213900-18-000250#line-1","is_derivative":false,"issuer_cik":"0001463414","issuer_name":"Citius Pharmaceuticals, Inc.","issuer_ticker":"CTXR","issuer_name_source":null,"issuer_url":"/issuer/0001463414","owner_cik":"0001463414","owner_name":"Mazur Leonard L","owner_display_name":"Mazur Leonard L","owner_url":"/insider/0001463414","role":"Director, Officer (Executive Chairman), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Chairman","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":213106.0,"shares_display":"213,106","price_per_share":4.69,"price_display":"4.69","price_state":"stated","total_value":999467.14,"total_display":"999,467.14","total_whole":"999,467","shares_owned_after":3550836.0,"shares_owned_after_display":"3,550,836","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-12-19","filed_date":"2018-01-08","scope":"insider"},{"id":5228647,"accession":"0001477932-17-004226","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001477932-17-004226","line_url":"/filing/0001477932-17-004226#line-1","is_derivative":false,"issuer_cik":"0001463414","issuer_name":"Citius Pharmaceuticals, Inc.","issuer_ticker":"CTXR","issuer_name_source":null,"issuer_url":"/issuer/0001463414","owner_cik":"0001463414","owner_name":"Mazur Leonard L","owner_display_name":"Mazur Leonard L","owner_url":"/insider/0001463414","role":"Director, Officer (Executive Chairman), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Chairman","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":11000.0,"shares_display":"11,000","price_per_share":2.68,"price_display":"2.68","price_state":"stated","total_value":29480.0,"total_display":"29,480.00","total_whole":"29,480","shares_owned_after":3337730.0,"shares_owned_after_display":"3,337,730","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-08-24","filed_date":"2017-08-28","scope":"insider"},{"id":5191929,"accession":"0001477932-17-003817","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001477932-17-003817","line_url":"/filing/0001477932-17-003817#line-2","is_derivative":false,"issuer_cik":"0001463414","issuer_name":"Citius Pharmaceuticals, Inc.","issuer_ticker":"CTXR","issuer_name_source":null,"issuer_url":"/issuer/0001463414","owner_cik":"0001463414","owner_name":"Mazur Leonard L","owner_display_name":"Mazur Leonard L","owner_url":"/insider/0001463414","role":"Director, Officer (Executive Chairman), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Chairman","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":421400.0,"shares_display":"421,400","price_per_share":4.125,"price_display":"4.12","price_state":"stated","total_value":1738275.0,"total_display":"1,738,275.00","total_whole":"1,738,275","shares_owned_after":1779663.0,"shares_owned_after_display":"1,779,663","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-08-08","filed_date":"2017-08-10","scope":"insider"},{"id":3268661,"accession":"0001477932-16-009673","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001477932-16-009673","line_url":"/filing/0001477932-16-009673#line-2","is_derivative":false,"issuer_cik":"0001463414","issuer_name":"Citius Pharmaceuticals, Inc.","issuer_ticker":"CTXR","issuer_name_source":null,"issuer_url":"/issuer/0001463414","owner_cik":"0001463414","owner_name":"Mazur Leonard L","owner_display_name":"Mazur Leonard L","owner_url":"/insider/0001463414","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000000.0,"shares_display":"5,000,000","price_per_share":0.6,"price_display":"0.60","price_state":"stated","total_value":3000000.0,"total_display":"3,000,000.00","total_whole":"3,000,000","shares_owned_after":5457143.0,"shares_owned_after_display":"5,457,143","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-03-30","filed_date":"2016-04-12","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":9,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":9,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":9},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001861657","name":"Hillstream BioPharma Inc.","url":"/issuer/0001861657","role":"Director","n_filings":1,"first_seen":"2022-01-18","last_seen":"2022-01-18"},{"type":"issuer","type_label":"ISSUER","cik":"0001506251","name":"Citius Pharmaceuticals, Inc.","url":"/issuer/0001506251","role":"Director, Officer (Executive Chairman), Ten percent owner","n_filings":8,"first_seen":"2016-04-12","last_seen":"2019-09-27"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001463414","retrieved_at":"2026-08-26T21:56:57+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}